Latest News About Diphtheria

Here are the latest publicly reported updates on diphtheria, with a focus on recent outbreaks and global responses.

Key points from recent sources

• African Region outbreaks in 2025: Several countries reported ongoing diphtheria activity with thousands of suspected cases and a rising regional risk due to case load and limited laboratory capacity. WHO flagged high regional public health risk for further geographic spread and emphasized DAT shortages and testing gaps as major constraints. In many of the affected areas, children and young adults are heavily impacted, highlighting immunity gaps despite vaccination programs.[4]
• Europe and Europe-adjacent contexts: After a 2022–2023 wave among migrants, Europe has continued to monitor diphtheria circulation and encouraged rapid diagnosis, vaccination catch-up, and genomic surveillance to guide outbreak response and antimicrobial stewardship. A 2024 development noted the designation of a WHO collaborating centre in Germany to strengthen diagnostics and surveillance for diphtheria globally, which could augment Europe’s readiness and cross-border coordination.[1][3]
• Global surveillance and response capacity: WHO and partner agencies have stressed the need for rapid detection, timely treatment with antitoxin where available, and vaccination to prevent outbreaks. Publications from 2022–2025 emphasize updating laboratory capacity, stockpiling diphtheria antitoxin, and improving antibiotic stewardship and testing to manage outbreaks effectively.[3][1][4]
• Regional vaccine and preparedness efforts: Vaccine supply, booster strategies, and primary immunization coverage remain central to reducing susceptibility in older children and adults, who can be affected during outbreaks when immunity wanes. Public health bodies continue to promote vaccination campaigns and strengthen surveillance and diagnostic capabilities to reduce mortality and transmission.[6][4]

What this means for Buffalo, NY, and the U.S.

• Diphtheria remains rare in the United States due to high vaccination coverage, but outbreaks in other regions underscore the importance of maintaining high immunization levels and being prepared for importation or travel-associated cases.[6]
• U.S. health systems monitor diphtheria through surveillance networks and clinical guidance; stockpiles of diphtheria antitoxin and rapid diagnostic capacity are important for any potential cases, though the risk to the U.S. remains low compared with endemic or outbreak settings abroad.[4]

Illustrative example

• Outbreak management priorities in affected regions include rapid case detection, timely antitoxin administration where indicated, antibiotic stewardship, vaccination catch-up to close immunity gaps, and strengthening genomic and laboratory surveillance to track transmission and antimicrobial resistance trends.[1][3][4]

Would you like a concise one-page brief tailored for public health updates or a chart showing reported diphtheria cases by region over the past few years? I can also summarize vaccination recommendations or provide links to official guidance from WHO and PAHO.[4][6]